Search

Home
Research
People
News
Publications
Vacancies
Events
Contact

Alboukadel Kassambara

Latest

Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

© 2026 Cavalli lab. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.

Cite